Govt decides to allow retail sale of Tamiflu

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 11:39 PM IST

The government today decided to allow retail sale of Oseltamivir, commonly known as Tamiflu, which is the only drug available to treat swine flu.

A senior Health ministry official told PTI that a decision has been taken to allow sale of Tamiflu, the generic name of Oseltamivir, through 480 select drug outlets across the country.

Delhi has 30 such pharmacists.

The drug would be available under the category in which drugs having narcotic substances are sold (Schedule X). While selling these drugs, pharmacists have to keep a record of prescriptions, name of the doctor who has prescribed it and the person to whom it was sold.

Once the notification is issued tomorrow, select pharmacists can procure the drug from six companies which have the permission to manufacture the medicine.

The decision was taken after a meeting chaired by Union Health Minister Ghulam Nabi Azad and attended by senior officials.

The six companies are Ranbaxy, Cipla, Metco, Hetero, Strides and Roche.

A total of 189 people have succumbed to swine flu in the country till date.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 14 2009 | 8:29 PM IST

Next Story